Related Experiment Video
Updated: Jun 27, 2026

07:53
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
A liposomal delivery vehicle for the anticancer agent gossypol
Guangxi Zhai1, Jun Wu, Xiaobin Zhao
1College of Pharmacy, Shandong University, Jinan 250012, P. R. China.
Anticancer Research
|November 28, 2008
Summary
This study shows that liposomes effectively deliver gossypol, a potential anticancer agent. The novel liposomal formulation demonstrated significant cytotoxicity against cancer cells in vitro.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Background:
- Gossypol is recognized as a promising anticancer therapeutic.
- Challenges exist in delivering gossypol effectively for cancer treatment.
Purpose of the Study:
- To evaluate a novel liposomal formulation for gossypol delivery.
- To assess the physical, chemical, and cytotoxic properties of gossypol-loaded liposomes.
Main Methods:
- Gossypol was encapsulated within liposomes.
- Liposome characterization included physical and chemical property assessments.
- In vitro cytotoxicity assays were performed on cancer cell lines.
Main Results:
- Gossypol was stably encapsulated in the liposomes.
- The liposomal formulation exhibited significant cytotoxicity against cancer cells.
- Liposomes demonstrated favorable physical and chemical characteristics for drug delivery.
Conclusions:
- Liposomes serve as an effective delivery system for gossypol.
- This liposomal formulation holds potential for anticancer drug development.
- Further research into liposomal gossypol is warranted for clinical applications.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

